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ABSTRACT 
 
Normally, urine flows down from kidneys to bladders. Vesicoureteral reflux (VUR) is the abnormal flow of urine from 
bladders back to kidneys. VUR commonly follows urinary tract infection and leads to renal infection. Fluoroscopic 
voiding cystourethrography and direct radionuclide voiding cystography have been clinical gold standards for VUR 
imaging, but these methods are ionizing. Here, we demonstrate the feasibility of a novel and nonionizing process for 
VUR mapping in vivo, called photoacoustic cystography (PAC). Using a photoacoustic (PA) imaging system, we have 
successfully imaged a rat bladder filled with clinically being used methylene blue dye. An image contrast of ~8 was 
achieved. Further, spectroscopic PAC confirmed the accumulation of methylene blue in the bladder. Using a laser pulse 
energy of less than 1 mJ/cm2, bladder was clearly visible in the PA image. Our results suggest that this technology 
would be a useful clinical tool, allowing clinicians to identify bladder noninvasively in vivo.  
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INTRODUCTION 
 
Vesicoureteral reflux (VUR), the retrograde flow of urine from the bladder into the upper urinary tract, is commonly 
diagnosed after patients (typically children) have a urinary tract infection. 1-3 By transporting bacteria from the bladder 
back to the upper urinary tract, VUR causes renal infections such as pyelonephritis. The immunological and 
inflammatory reaction due to the renal infection may cause renal injury or scarring. Severe renal scarring may reduce 
renal function and produce severe side effects, including renal insufficiency, endstage renal disease, renin-mediated 
hypertension, decreased somatic growth, and morbidity during pregnancy. Early detection and treatment of VUR is 
essential. Two main methods have been used to evaluate VUR: fluoroscopic voiding cystourethrography (VCUG) and 
direct radionuclide voiding cystography (DRNC) 2. Although radiation dose reduction has been achieved in fluoroscopic 
VCUG, this method is still ionizing. Further, despite the smaller radiation dose of DRNC, this technique suffers from 
low spatial resolution, and patients are still exposed to radiation. The pediatric VUR guidelines panel of the American 
Urological Association strongly urges the development of techniques with less radiation exposure. 1,3 Echo-enhanced 
urosonography has been recently applied to monitor VUR, and it offers the advantages of nonionizing, real-time, and 
portable imaging capability. 2 However, ultrasound (US) imaging suffers from low image contrast because of speckle 
artifacts. Therefore, US imaging alone cannot be used for VUR tracking.   
Photoacoustic (PA) imaging is a non-ionizing and noninvasive imaging technique that can supply strong 
optical absorption contrast with high ultrasonic spatial resolution. 4 In PA imaging, a short-pulsed laser is used to 
irradiate the tissue, and the PA waves excited via thermoelastic expansion. The generated PA waves propagate in the 
medium and are then detected by an ultrasonic transducer. The acquired PA data based on the arrival times of the 
acoustic waves are used to quantify the optical absorption distribution. PA image contrast is determined by optical 
absorption in the PA excitation phase, whereas its resolution is mainly derived from ultrasonic detection in the PA 
emission phase. Most importantly, the PA amplitudes are directly proportional to optical absorption coefficients of 
targets, which are strongly related to oxygen saturation and total concentration of hemoglobin. Recently, PAT has been 
extensively explored in preclinical and clinical studies, including primary cancer detection, lymph node staging and 
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lymphangiography, brain activation, ophthalmology, image-guided therapy, etc. 5-9 A clinical ultrasonic scanner has 
been adapted to PAT, combining the high contrast of optical imaging and the high resolution of ultrasound imaging. 10-13 
In this proceedings, for the first time to our knowledge, we describe the feasibility of a novel and safe 
approach for VUR monitoring using PAT, referred to as photoacoustic cystography (PAC). As the first step, a 
healthy rat bladder filled with methylene blue was photoacoustically imaged in vivo without any ionizing 
radiation.            
 
METHODS AND MATERIALS 
 
A photograph of a dark-field confocal photoacoustic imaging system 14 is shown in Figure 1. A tunable OPO laser (400 
- 2300 nm, Surelite III OPO, Continuum), pumped by a Q-switched Nd:YAG laser with 6-ns pulse duration and 10-Hz 
pulse repetition rate, is used as a light source. A light wavelength of 667 nm was used for most of the experiments, but 
both 667 and 850 nm optical wavelengths were used for spectroscopic bladder identification. Formed by a spherical 
conical lens and an optical condenser, the donut-shaped light illumination was coaxially aligned with the ultrasound 
focus in water. Dark-field confocal configuration provided a greater penetration depth and higher SNR. The light 
fluences on the skin were less than 1 mJ/cm2, within the ANSI limit. A 5-MHz single-element ultrasound transducer 
was used as a detector. The axial and transverse resolutions are 144 μm and 590 μm, respectively. The scanning speed 
for one PA image was ~ 25 minutes, with a field of view (FOV) of 2.5 × 2.5 cm in x and y axes, respectively. No signal 
was averaged. By measuring PA amplitudes according to their arrival times, one-dimensional depth-resolved image 
could be acquired, referred to as an A-line. Additional raster scanning along the one transverse direction enables the 
formation of two-dimensional depth-resolved images (B-scans). The acquired two-dimensional raw data can be 
processed: a maximum amplitude projection (MAP), a projection of the maximum PA amplitude along each A-line onto 
the corresponding plane. 
 
 
 
Figure 1: Schematic and photograph of volumetric photoacoustic imaging system. (a) Schematic of the dark-field light illuminaton 
PA system. (b) Photograph of the PA system. OPO laser; Optical parametric oscillator laser.  
 
Spraque-Dawley rats weighing about 250 g were used for the in-vivo experiments. All in vivo animal 
experiments were carried out in compliance with the Institutional Animal Care and Use Committee. The rats were 
initially anesthetized with a mixture of ketamine (85 mg/kg) and xylazine (15 mg/kg). After depilation in the abdominal 
region, the rats were positioned atop a home-made holder (Figure 2a). The distal end of a 22 gauge catheter was coated 
with lubricant. After the urinary meatus was identified, the catheter was gently inserted until urine was noted. Then, 
urine in the bladder was allowed to void through the catheter. Before injection of dye, we obtained a control image. 
Figure 2b is a photograph of a rat taken prior to PA image acquisition and after hair removal and catheterization. After 
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injection of methylene blue, with a concentration of 30 mM and a dose of 0.2 ml via the catheter, we acquired a series 
of PA images. Figure 2c shows a photograph of the same region with skin removed and shows the bladder containing 
methylene blue after the PA imaging.  
 
 
 
Figure 2: (a) Photography of an animal with bladder catherization and animal holder. (b) Photograph with hair removed before 
photoacoustic imaging. (c) Photography with skin removed after photoacoustic imaging.  
 
RESULTS AND DISCUSSIONS 
 
The pre-injection control PA image was obtained at a wavelength of 667 nm, where the optical absorption of methylene 
blue is peak, and is shown in the form of maximum amplitude projection (MAP) in Figure 3a. The vasculature in the 
abdominal area was clearly imaged with high contrast. The bladder was not visible in the control PA image because 
urine in the bladder was optically transparent at the 667 nm wavelength. The bladder appeared clearly in the PA image 
acquired after methylene blue injection. Because methylene blue has higher optical absorption than blood at the 667 nm 
wavelength, the bladder appeared with a much higher contrast than the surrounding blood vessels (Figure 3b). 
 
 
 
Figure 3: In vivo nonionizing and noninvasive PA bladder imaging in a rat using methylene blue injection. (a) Control PA image at 
667 nm without methylene blue. (b) PA image acquired at 667 nm after injection.  
 
The bladder filled with methylene blue is also clearly mapped in the depth-resolved PA B-scan image (Figure 
3). The bladder was positioned ~ 2 mm below the skin surface. Again, the bladder was invisible in the control PA B-
scan image (Figure 4a). The accumulation of methylene blue in the bladder was visually identified in a photograph of 
the same rat with the skin removed after PA imaging (Figure 4b).  
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Figure4: B-scan PA images of bladder before and after injection of methylene blue. (a) Control B-scan PA image. (b) B-scan PA 
image after injection. 
 
 
CONCLUSIONS 
 
In summary, we have shown the feasibility of a new and safe imaging method for tracking VUR. Conventional imaging 
techniques suffer from either ionizing radiation or low image contrast. For the first step, photoacoustically and 
spectrally imaged a rat bladder filled with clinically used methylene blue dye in vivo. The nonionizing PAC can 
completely avoid radiation exposure to child subjects. Once it is combined with a conventional US imaging probe, this 
technique can be portable, fast, and cost effective. In the future, we will investigate the PA VUR mapping in a porcine 
model. In addition, PAC can be potentially used for other urologic diseases such as bladder cancers. Once it is 
combined with a conventional US imaging probe, this technique can be portable, fast, and cost effective. In the future, 
we will investigate the PA VUR mapping in a porcine model. In addition, PAC can be potentially used for other 
urologic diseases such as bladder cancers. 
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